Invention Grant
- Patent Title: Blockade of RGMb for reducing transplantation-associated immune responses
-
Application No.: US15343085Application Date: 2016-11-03
-
Publication No.: US10093734B2Publication Date: 2018-10-09
- Inventor: Everett Hurteau Meyer , Rosemarie H. Dekruyff , Panagiota Iliopoulou , Yuchiao Hsu , Magdiel Perez Cruz
- Applicant: The Board of Trustees of the Leland Stanford Junior University
- Applicant Address: US CA Stanford
- Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee Address: US CA Stanford
- Agency: Bozicevic, Field & Francis LLP
- Agent Pamela J. Sherwood
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K45/06 ; C07K16/22 ; A61K39/00
Abstract:
RGMb antagonists reduce undesirable immune responses associated with tissue or organ transplantation.
Public/Granted literature
- US20170121404A1 BLOCKADE OF RGMb FOR REDUCING TRANSPLANTATION-ASSOCIATED IMMUNE RESPONSES Public/Granted day:2017-05-04
Information query
